NCT04278300View on ClinicalTrials.gov

Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD)

CompletedOBSERVATIONAL

Enrollment

205

Participants

Timeline

Start Date

February 11, 2020

Primary Completion Date

August 21, 2020

Study Completion Date

September 9, 2020

Conditions

Age-related Macular Degeneration

Interventions

BIOLOGICAL

blood sampling

dosage of omega 3 polyunsaturated fatty acids, search for age-related macular degeneration susceptibility genese

BIOLOGICAL

faecal sampling (optional)

analysis of the microbiota by DNA sequencing

Trial Locations (1)

21079

CHU dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04278300 - Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD) | Biotech Hunter | Biotech Hunter